CVRx
Latest round
- Series G
Last raised
- Jul 2020
Total raised
- $252M
Investors
- 19
About CVRx
Based in Minnesota, US, CVRx, Inc. was founded in 2001. The company is a private medical device company that is treating chronic heart failure ("HF") and resistant hypertension in individuals. In April 2021, the company filed on NASDAQ to become a public company. The company's technology Barostim neo™ is designed to treat high blood pressure and heart failure by triggering the body's own natural blood flow control mechanism, allowing patients to begin therapy sooner and increasing the probability of a good outcome. The company plans to be listed on the Nasdaq under the symbol CVRX.
Who invested in CVRx
19 investors across 6 rounds
See all investors in CVRx
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CVRx
Who invested in CVRx?
CVRx has 19 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CVRx raised?
CVRx has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did CVRx last raise money?
CVRx's most recent round on record is a Series G, in Jul 2020.
What does CVRx do?
Based in Minnesota, US, CVRx, Inc.
Where is CVRx headquartered?
CVRx is headquartered in Minneapolis, US.
Which VCs invest in companies like CVRx?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at CVRx's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series G
Raising like CVRx? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.